Rotavirus Vaccine Completed Phase 2 Trials for Infections, Rotavirus / Rotavirus Gastroenteritis Prevention

CompletedPrevention2 IdentifierTitleDrugs
NCT00263666A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa
NCT00432380A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
NCT00425737Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants